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Case Report
INTRODUCTION
Extramedullary plasmacytoma (EMP) is a rare plasma cell neo-
plasm that occurs mainly in the soft tissues of head and neck re-
gion, with the paranasal sinuses, nasal cavity and nasopharynx 
being the most common sites (1, 2). EMPs represent 4% of all 
plasma cell neoplasma (3). EMP is distinct from solitary plasma-
cytoma of the bone and from multiple myeloma, because EMP 
is usually a localized disease and associated with a favorable 
prognosis (4).
  Solitary EMP of the larynx comprising approximately six to 
eighteen percent of all EMPs is very rare but increasingly report-
ed recently (5). Common sites of involvement in the larynx in 
the order of frequency are the epiglottis, ventricles, vocal folds 
and ventricular folds (6). 
  We report an extremely rare case of solitary EMP involving in 
the apex of arytenoids that was treated by only surgical excision. 
We review the literatures of this rare but interesting lesion and 
present the endoscopic, computerized tomography (CT) and 
pathologic findings.
CASE REPORT
The patient was a 58-year-old healthy male who presented with 
a laryngeal mass incidentally discovered in the course of gastros-
copy for a periodic medical check-up. He had no symptoms, in-
cluding hoarseness, globus sensation, dysphagia or dyspnea. He 
had no previous medical history and prior history of intubation. 
Laryngeal examination revealed a clearly demarcated, localized 
mass in the apex of left arytenoid. The lesion was a reddish, pol-
ypoid growth (Fig. 1). The mobility of vocal cord was intact. No 
lymph node enlargement was clinically detected. CT of the neck 
revealed a well demarcated, minimally enhancing, 1.5×1.0×1.2 
cm sized mass in the left arytenoid region (Fig. 2).
  The patient underwent a direct laryngoscopy under general 
anesthesia. The tumor was noted to involve the apex of left ary-
tenoid and presented as a reddish, smooth polypoidal growth 
with narrow base. The patient had undergone complete surgical 
excision with negative margins but minimal bleeding was noted. 
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Histopathology revealed a dense monoclonal infiltrate of plasma 
cells with eccentrically situated nuclei with mild degree of nu-
clear polymorphism (Fig. 3). The histological diagnosis of plas-
macytoma was made. Immunohistochemistry was done for kap-
pa and lambda light chains and was positive for lambda chains, 
which confirmed the monoclonal nature of the plasma cells (Fig. 
4). Multiple laboratory and radiological studies were performed 
in order to rule out systemic plasmacytoma. Serum protein elec-
trophoresis, immunoelectrophoresis and scintigraphy were nor-
mal. Urine examination for light chains was negative. The full 
blood count and levels of serum calcium, creatinine and uric acid 
were within the normal range. Bone marrow aspiration from the 
iliac crest was normal on cytological examination and showed 
no evidence of plasma cell infiltration. A radiological skeletal 
survey was performed which showed no evidence of lytic lesions 
in the skull, vertebral column or bones of the chest wall or pel-
vis. A diagnosis of extramedullary plasmacytoma of the apex of 
arytenoids was made. Because the resected margin was histo-
Fig. 1. Laryngeal examination revealed a mass clearly demarcated, localized in the apex of left arytenoid. The lesion was a reddish, polypoid 
growth.
Fig. 2. Computerized tomography of the neck revealed a well demarcated, minimally enhancing, 1.5×1.0×1.2 cm sized mass in the left aryte-
noid region.
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logically free of tumor cells, no further therapy including adju-
vant radiotherapy was administered. He has remained clear, with 
no local recurrence during 2 years of follow-up.
DISCUSSION
EMPs constitute less than 1% of the malignancies in the head 
and neck region and less than 0.2% of the malignancies in the 
larynx (7, 8). In the present case, the apex of arytenoids is ex-
tremely rare involved site and there are few reported cases in 
English literatures (9).
  EMP of the larynx occurs in men approximately three times 
more often than in women, and is generally seen at the age of 
40-70 years (3, 6, 10).
  Although the clinical presentation varies according to the in-
volved organ (3), the clinical appearance of EMP of the larynx 
is not specific and related to compression and obstruction of lo-
Fig. 3. Histopathology revealed a dense monoclonal infiltrate of plasma cells with eccentrically situated nuclei with mild degree of nuclear poly-
morphism (A: ×200, B: ×400). 
A B
Fig. 4. Immunohistochemistry was done for kappa (A) and lambda light chains (B) and was positive for lambda chains, which confirmed the 
monoclonal nature of the plasma cells (×200).
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cal structures (11). The most common symptom is slowly pro-
gressive hoarseness. Late symptoms are dysphagia, stridor, and 
pain associated with locally aggressive tumors (5). Acute airway 
obstruction requiring intubation is an extremely rare event and 
may represent hemorrhage within the tumor or secondary bac-
terial infection (12).
  In the present case, he had no clinical presentation and the le-
sion was incidentally discovered in the course of gastroscopy. We 
think that EMPs of the apex of arytenoids could be free of symp-
tom and incidentally discovered.
  The diagnosis of EMP is confirmed by histopathologically prov-
en proliferation of neoplastic plasma cells and systemic exami-
nations that rule out bone involvement through bone surveys, 
chest X-rays, peripheral blood tests and bone marrow biopsies 
(13).
  According to the laryngoscopic view, EMPs of the larynx arise 
in the submucosa and vary from smooth polypoidal growths with 
narrow bases to sessile lesions with wide attachments. The tu-
mors may be red or pale pink. These tumors are reportedly vas-
cular and bleed readily with operative trauma (10). In the pres-
ent case, the tumor arose in the apex of left arytenoid and pre-
sented as a red, polypoid growth with narrow base. Also, the tu-
mor was not vascular and minimal bleeding was noted during 
complete excision. 
  No pathognomonic or characteristic radiological findings of 
EMP involved in the larynx have been reported since. Although 
our patient was not a typical case, neck CT with contrast en-
hancement was performed and showed well demarcated and 
minimally enhancing mass in the left arytenoid. 
  EMPs of the larynx should be differentiated from the larynge-
al malignancies and benign tumors, including laryngeal granulo-
ma and papilloma in view of laryngoscopic findings. Laryngeal 
granulomas, in particular, should be included in the differential 
diagnosis for solitary EMP involved in the arytenoid area like 
our case because there are several points of similarity between 
the two (14).
  First, they are somewhat similar in the involved site. Larynge-
al granulomas are benign lesions of the posterior glottis that are 
commonly centered in the tips of the cartilaginous vocal pro-
cesses of the arytenoids. Second, laryngoscopic findings of la-
ryngeal granuloma are also pale, sometimes red mass-like lesion 
and may appear as solitary or bilobed. Third, both diseases com-
monly present with hoarseness. 
  However, there is an important difference between them in 
points of treatment. The primary management of laryngeal gran-
uloma is management of the underlying laryngopharyngeal re-
flux. Most granulomas resolve with medical management. Al-
though surgical biopsy can be a differential diagnostic method, 
surgical excision may be considered for laryngeal granuloma 
under three conditions: 1) for biopsy, when the possibility of 
carcinoma exists; 2) for airway obstruction, if the granulomas 
are quite large; 3) to restore the voice in selected cases (14). 
  There are no general guidelines for the treatment of patients 
with EMP. The rarity of this tumor and its long natural history 
make determination of the optimal treatment strategy and prog-
nostic factors difficult, which has resulted in a lack of consensus 
on how best to manage this condition (11). However, Radiother-
apy is accepted as the standard treatment for EMP because of 
its high radiosensitivity. The optimal dosage regimen for radio-
therapy is a matter of debate (7). Although EMP of the larynx 
should be treated basically by radiotherapy, surgical resection is 
beneficial in the treatment of small EMP of the larynx. Thus, 
small, pedunculated and localized lesions could be completely 
removed by laryngeal microsurgery (9, 10). The larger lesions, 
however, necessitating major surgery and sacrificing laryngeal 
function, are best treated by radiotherapy (9).
  In the present case, because the tumor was small and local-
ized in the apex of left arytenoid, our patient had undergone 
only complete surgical excision with negative margins instead of 
recommendation for adjuvant radiotherapy.
  In general, EMP of the head and neck has a better prognosis 
than solitary bone plasmacytoma or multiple myeloma. This may 
be due to early presentation, when the lesions are small and well 
localized and also probably due to easy accessibility of the tumor 
to examination (7, 11). Because the small number of patients 
with EMP of the larynx was reported, the prognosis has not 
been reported, but the results of treatment were always good.
  The evolution of EMP to multiple myeloma is the determi-
nant factor for survival. Only 10% to 30% of cases progress to 
multiple myeloma within 2 years, but the prognosis for these 
patients is poor (15). Several factors predictive of progression to 
multiple myeloma have been reported, such as the size of the 
tumor at diagnosis, total serum protein level, and a monoclonal 
spike observed on serum protein electrophoresis (16). Because 
recurrence is usually within 24 months but may be as late as 10 
years after treatment, long-term follow-up, including not only 
local control but also systemic observation via blood counts and 
immunoglobulin measurement, is necessary (7, 17).
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